Skip to main content

Opiate Addiction

1
Pipeline Programs
7
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
1
Magnitude GroupPhase 21 trial
Active Trials
NCT03831113Terminated13Est. Dec 2022
Orexo
OrexoNJ - Morristown
1 program
AiCure monitoring and interventionN/A1 trial
Active Trials
NCT02243670Completed9Est. Mar 2017
MSD
MSDIreland - Ballydine
1 program
NexplanonN/A1 trial
Active Trials
NCT02657148Completed200Est. Aug 2018
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
NexplanonN/A
Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
NexplanonN/A
Jazz Pharmaceuticals
Jazz PharmaceuticalsCA - Palo Alto
1 program
CBD 400 mgPHASE_21 trial
Active Trials
NCT02539823Completed45Est. May 2017
US WorldMeds
US WorldMedsKY - Louisville
1 program
LofexidinePHASE_31 trial
Active Trials
NCT00235729Completed264Est. Oct 2007

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
US WorldMedsLofexidine
Human BioSciencesMagnitude Group
Jazz PharmaceuticalsCBD 400 mg
OrexoAiCure monitoring and intervention
MSDNexplanon

Clinical Trials (5)

Total enrollment: 531 patients across 5 trials

NCT00235729US WorldMedsLofexidine

Lofexidine for Inpatient Opiate Detox

Start: Jun 2006Est. completion: Oct 2007264 patients
Phase 3Completed
NCT03831113Human BioSciencesMagnitude Group

Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy

Start: Apr 2019Est. completion: Dec 202213 patients
Phase 2Terminated
NCT02539823Jazz PharmaceuticalsCBD 400 mg

Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans

Start: Sep 2015Est. completion: May 201745 patients
Phase 2Completed
NCT02243670OrexoAiCure monitoring and intervention

Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy

Start: Aug 2016Est. completion: Mar 20179 patients
N/ACompleted
NCT02657148MSDNexplanon

Immediate Postpartum Nexplanon Placement in Opioid Dependent Women

Start: May 2016Est. completion: Aug 2018200 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.